Daily observation of inhalation of Tobramycine Inhalation Powder (TIP)
Recruiting
- Conditions
- Cystic FibrosisTaaislijmziekteInhalationprofileInhalatieprofielDepositionDepositie
- Registration Number
- NL-OMON24275
- Lead Sponsor
- Erasmus MC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 32
Inclusion Criteria
Proven CF
Maintenance treatment with TIP
Exclusion Criteria
Respiratory tract exacerbation at time of TIP month defined as treatment with intravenous antibiotics
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The main study parameter is the percentage of patients who inhale with a slow/ intermediate/ fast inhalation maneuver while inhaling TIP.
- Secondary Outcome Measures
Name Time Method Secondary study parameters are: Difference in percentage of patients who react with cough immediately during or following TIP inhalation for the slow/intermediate/fast inhalation maneuver, prevalence of errors made in TIP inhalation in the home situation according to scoring items list, percentage of patients able to execute a slow and deep inhalation using TIP, and tidal volume pattern while patients are inhaling from a conventional nebulizer